Eldecalcitol-d6

• CAT Number: S000545
• Molecular Formula: C30H44D6O5
• Molecular Weight: 496.75
• Purity: ≥95%
• Target: VD/VDR
• IUPAC Name: (1R,2R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-7,7,7-trideuterio-6-hydroxy-6-(trideuteriomethyl)heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-2-(3-hydroxypropoxy)-4-methylidenecyclohexane-1,3-diol
• InChI: InChI=1S/C30H50O5/c1-20(9-6-15-29(3,4)34)24-13-14-25-22(10-7-16-30(24,25)5)11-12-23-19-26(32)28(27(33)21(23)2)35-18-8-17-31/h11-12,20,24-28,31-34H,2,6-10,13-19H2,1,3-5H3/b22-11+,23-12-/t20-,24-,25+,26-,27-,28-,30-/m1/s1/i3D3,4D3
• InChIKey: FZEXGDDBXLBRTD-WEKSAGPESA-N
• SMILES: CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(C(C(C3=C)O)OCCCO)O)C

Eldecalcitol-d6（Cat No.:S000545） is a specialized form of eldecalcitol, a synthetic analog of vitamin D used in the treatment of osteoporosis. The “d6” designation indicates that six hydrogen atoms in the eldecalcitol molecule are replaced with deuterium, a stable isotope of hydrogen. This isotopic labeling enables precise tracking of eldecalcitol metabolism and its pharmacokinetics using advanced analytical techniques like mass spectrometry. Eldecalcitol-d6 serves as a valuable tool in pharmacological studies, aiding in elucidating drug metabolism, understanding its cellular effects, and investigating its efficacy and safety profiles in the treatment of osteoporosis.